Investigational Dengue Vax Has Gaps

Analysis suggests it's more effective in older children. The analysis also showed that overall the vaccine was associated with a reduction in the rate of hospital admission for dengue, a marker used as a surrogate for safety, Saville and colleagues reported online in the New England Journal of Medicine. But the safety analysis was complicated, they noted, because the vaccine appeared to be less safe for children under 9 than for those 9 or older, with relative risks of dengue admission of 1.58 and 0.50, respectively. http://www.medpagetoday.com/InfectiousDisease/Vaccines/52797?xid=nl_mpt_DHE_2015-07-28&eun=g721819d0r